News

Noncommunicable Disease Looks Different in the "Bottom Billion"


 

FROM A CONFERENCE ON NONCOMMUNICABLE DISEASES IN THE BOTTOM BILLION

District hospital leaders work closely with the staff of health centers, providing training, mentoring, and education, with the idea of reducing the need to transfer patients to referral centers. Each Partners In Health–supported district hospital in Rwanda has an advanced chronic care clinic for noninfectious diseases. Countries such as Rwanda that already have such integrated programs to address HIV/AIDS can more easily and less expensively integrate NCDs into their health systems, Dr. Bukhman noted.

Dr. Farmer, chair of the department of global health and social medicine at Harvard, stressed the need for "health systems strengthening" and for partnerships between governments, academia, nongovernmental organizations, private industry, and other stakeholders in order to tackle the complexity and heterogeneity of the endemic NCDs.

"It can’t be diabetes versus mental health or rheumatic heart disease versus cancer. It has to be a very collaborative effort that draws on partnerships and synergies. ... In building platforms for the delivering of care for chronic disease, we need to do many things at once."

Dr. Hotez disclosed that he has a patent on a hookworm vaccine, but no relationships with pharmaceutical companies. Dr. Mocumbi stated that she has no disclosures. Dr. Salvi disclosed that he has received fees from Merck Pharmaceuticals as an advisory board member and speaker. Partners In Health receives funding from corporate donors, including several pharmaceutical companies.

Pages

Recommended Reading

Two Successful Phase III Trials for Topical Naftifine 2% Cream
MDedge Internal Medicine
Two Successful Phase III Trials for Topical Naftifine 2% Cream
MDedge Internal Medicine
Tailor Antibiotic Dose to Weight Before Cesarean
MDedge Internal Medicine
Varicella Shedding Detected Up to Month After Zoster Vaccination
MDedge Internal Medicine
CDC Funds Research to Prevent Healthcare Acquired Infections
MDedge Internal Medicine
MRSA Often Hides in Places Other Than the Nose
MDedge Internal Medicine
Zostavax Effective Against Herpes Zoster in 50- to 59-Year-Olds
MDedge Internal Medicine
IV Hydrocortisone Cuts Pneumonia in Intubated Trauma Patients
MDedge Internal Medicine
FDA Approves Shingles Vaccine for Ages 50-59
MDedge Internal Medicine
Reduced Rabies Postexposure Prophylaxis Endorsed by AAP
MDedge Internal Medicine

Related Articles